MedTrace Logo

Personalised Postoperative Radiochemotherapy in Patients With Head and Neck Cancer

NCT02666885 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2019-09-24

No results posted yet for this study

Summary

The current trial is evaluating the integration of a pretherapeutical FDG-PET/MRI in the adjuvant radiochemotherapy in patients with head and neck cancer. As a secondary hypothesis the intention is to develop of a multi-parametric decision support system for personalised medicine by integrating functional imaging, γH2AX-analysis and genetic information.

Conditions

Interventions

RADIATION

Integration of PET/MRI in radiotherapy

Integration of pretherapeutical PET/MRI in adjuvant radiotherapy

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Daniel Zips, MD, Prof · University Hospital Tuebingen, Department of Radiation Oncology, Tuebingen, Germany

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2019-06-30
Completion
2019-08-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02666885 on ClinicalTrials.gov